{"disease":{"id":"iga-vasculitis","name":"iga vasculitis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06065852","title":"National Registry of Rare Kidney Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":35000,"lead_sponsor_name":"UK Kidney Association","has_results":false},{"nct_id":"NCT03410290","title":"Journey of Patients With Vasculitis From First Symptom to Diagnosis","phase":"","overall_status":"COMPLETED","enrollment_count":456,"lead_sponsor_name":"University of Pennsylvania","has_results":false},{"nct_id":"NCT07354503","title":"Telitacicept in the Treatment of Pediatric IgA Vasculitis-Associated Nephritis","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":300,"lead_sponsor_name":"The Children's Hospital of Zhejiang University School of Medicine","has_results":false},{"nct_id":"NCT04008316","title":"Efficacy of Colchicine to Prevent Skin Relapses in Adult's IgA Vasculitis","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":264,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT02939573","title":"A Randomized Multicenter Study for Isolated Skin Vasculitis","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"University of Pennsylvania","has_results":false},{"nct_id":"NCT05329090","title":"Evaluation of Glucocorticoids Plus Rituximab in Patients with Newly-Diagnosed or Relapsing IgA Vasculitis","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":75,"lead_sponsor_name":"Hopital Foch","has_results":false},{"nct_id":"NCT05003986","title":"Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":67,"lead_sponsor_name":"Travere Therapeutics, Inc.","has_results":false},{"nct_id":"NCT07389499","title":"A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in the Treatment of Immune-mediated Kidney Diseases","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Grit Biotechnology","has_results":false},{"nct_id":"NCT07024563","title":"Study of Ravulizumab in Pediatric Participants With Primary IgAN","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":24,"lead_sponsor_name":"Alexion Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT05168475","title":"Biologics in Refractory Vasculitis: A Trial of Biologic Therapy for Refractory Primary Non-ANCA Associated Vasculitis","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":22,"lead_sponsor_name":"Cambridge University Hospitals NHS Foundation Trust","has_results":true}],"total":10},"guidelines":[],"source":"Drug Landscape verified database"}